News|Articles|October 16, 2020
- Pharmaceutical Technology-10-15-2020
- Volume 2020 eBook
- Issue 3
Due Diligence Assessment of CMC Activities
Author(s)William J. Lambert
For planned acquisitions or licensing, a careful analysis of CMCl factors is vital to ensure no problem areas are overlooked.
Advertisement
Developing comprehensive chemistry, manufacturing, and controls programs are crucial to the success of a drug product. For planned acquisitions or licensing, a careful analysis of these critical factors is vital to ensure no problem areas are overlooked. Strategies for carrying out an effective due diligence exercise are described.
Article Details
Pharmaceutical Technology
eBook: Regulatory Sourcebook
October 2020
Pages: 26–28
Citation
When referring to this article, please cite it as W. Lambert, “Due Diligence Assessment of CMC Activities," Pharmaceutical Technology Regulatory Sourcebook eBook (October 2020).
Articles in this issue
about 5 years ago
Enhancing Process Validation for Solid Oral Dosage Forms: Part 2about 5 years ago
Tackling Cybersecurity Challenges in Legacy Systemsabout 5 years ago
Ending ‘Magical Thinking’ in Compoundingabout 5 years ago
Viral Vector API Characterization of Product-Related Impuritiesabout 5 years ago
Strong Quality Culture: A How-To for Busy Managersabout 5 years ago
Resources, Guidelines, and Guidance Documentsabout 5 years ago
Regulatory and Standard Setting OrganizationsNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
